These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35534880)

  • 21. A Comparison of Objectively Measured Free-Living Physical Behaviour in Adults with and without Lower Limb Amputation.
    Deans S; Kirk A; McGarry A; Rowe DA; Dall PM
    Int J Environ Res Public Health; 2023 Jun; 20(13):. PubMed ID: 37444046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.
    Mohammedi K; Bellili-Muñoz N; Marklund SL; Driss F; Le Nagard H; Patente TA; Fumeron F; Roussel R; Hadjadj S; Marre M; Velho G
    Cardiovasc Diabetol; 2015 Jan; 14():845. PubMed ID: 25855220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes.
    Abola MT; Bhatt DL; Duval S; Cacoub PP; Baumgartner I; Keo H; Creager MA; Brennan DM; Steg PG; Hirsch AT;
    Atherosclerosis; 2012 Apr; 221(2):527-35. PubMed ID: 22321872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
    Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
    Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.
    Bertrand C; Saulnier PJ; Potier L; Croyal M; Blanchard V; Gand E; Ragot S; Schneider F; Bocock O; Baillet-Blanco L; Velho G; Marre M; Roussel R; Rigalleau V; Hadjadj S; Mohammedi K;
    Diabetologia; 2021 Mar; 64(3):668-680. PubMed ID: 33409569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
    Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
    Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease.
    Salinero-Fort MA; Mostaza J; Lahoz C; Cárdenas-Valladolid J; Vicente-Díez JI; Gómez-Campelo P; de Miguel-Yanes JM
    BMC Geriatr; 2022 Mar; 22(1):224. PubMed ID: 35303825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective study of cardiovascular disease risk factors among a cohort of combat veterans with lower limb amputation.
    Bhatnagar V; Richard E; Melcer T; Walker J; Galarneau M
    Vasc Health Risk Manag; 2019; 15():409-418. PubMed ID: 31571892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study.
    Resnick HE; Carter EA; Lindsay R; Henly SJ; Ness FK; Welty TK; Lee ET; Howard BV
    Diabetes Care; 2004 Jun; 27(6):1286-93. PubMed ID: 15161777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes.
    Potier L; Roussel R; Marre M; Bjornstad P; Cherney DZ; El Boustany R; Fumeron F; Venteclef N; Gautier JF; Hadjadj S; Mohammedi K; Velho G
    Diabetes Care; 2019 Dec; 42(12):2290-2297. PubMed ID: 31582427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of lower limb amputation in people with and without diabetes: a nationwide 5-year cohort study in Japan.
    Kamitani F; Nishioka Y; Noda T; Myojin T; Kubo S; Higashino T; Okada S; Akai Y; Ishii H; Takahashi Y; Imamura T
    BMJ Open; 2021 Aug; 11(8):e048436. PubMed ID: 34404707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community ambulation in people with lower limb amputation: An observational cohort study.
    Damiani C; Pournajaf S; Goffredo M; Proietti S; Denza G; Rosa B; Franceschini M; Casale R
    Medicine (Baltimore); 2021 Jan; 100(3):e24364. PubMed ID: 33546072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity.
    Stamler J; Daviglus ML; Garside DB; Dyer AR; Greenland P; Neaton JD
    JAMA; 2000 Jul; 284(3):311-8. PubMed ID: 10891962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry.
    Hallström S; Svensson AM; Pivodic A; Ólafsdóttir AF; Löndahl M; Wedel H; Lind M
    Diabetologia; 2021 Dec; 64(12):2751-2761. PubMed ID: 34494137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Schade D; Braffett B; Kosiborod M; Lopes-Virella M; Soliman EZ; Herman WH; Bluemke DA; Wallia A; Orchard T; Lachin JM;
    Diabetes Care; 2020 Apr; 43(4):867-874. PubMed ID: 32001614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical Function and Pre-Amputation Characteristics Explain Daily Step Count after Dysvascular Amputation.
    Miller MJ; Cook PF; Kline PW; Anderson CB; Stevens-Lapsley JE; Christiansen CL
    PM R; 2019 Oct; 11(10):1050-1058. PubMed ID: 30729727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of lower limb amputations in individuals with and without diabetes mellitus in Andalusia (Spain) from 1998 to 2006.
    Almaraz MC; González-Romero S; Bravo M; Caballero FF; Palomo MJ; Vallejo R; Esteva I; Calleja F; Soriguer F
    Diabetes Res Clin Pract; 2012 Mar; 95(3):399-405. PubMed ID: 22133651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
    Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Factor of Lower Limb Amputation among Diabetic Foot Ulcer Patients in North-East Peninsular Malaysia.
    Rosedi A; Hairon SM; Abdullah NH; Yaacob NA
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36361092
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.